Xeris Biopharma Reports Third Quarter 2022 Financial Results and Recent Events streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Xeris Biopharma Holdings Inc (NASDAQ:XERS) has announced positive topline results from its Phase 1 study of subcutaneous (SC) levothyroxine (XP-8121) in.
Xeris Biopharma Holdings (NASDAQ:XERS) Inc has noted that Tetris Pharma - its commercialization partner for Ogluo in the UK, EEA, and Switzerland - is to be.
PowerTap Hydrogen Capital Corp has issued an update on its 49%-owned Progressus Clean Technologies Inc subsidiary, noting that the company executed a Letter.